Increasing living donor kidney transplantation numbers in Budapest

Transplant Proc. 2013;45(10):3678-81. doi: 10.1016/j.transproceed.2013.10.001.

Abstract

Living related kidney donations (LRD) have had a significant impact on therapy of kidney diseases. Due to their ease of scheduling in the general surgery program and better half-life of about 21.6 versus 13.8 years for deceased donor kidneys, this approach has revolutionized nephrology and transplantation medicine. Since the first Hungarian LRD which was performed in 1974 in Budapest, Hungary, donations have expanded especially in the last 3 years. This has been followed in 2000 by living unrelated kidney donations (LURD). Since 2000 LURD can be also performed in Hungary. From the 251 LRD in our country in the last 3 years, 79 living donations have accounted for nearly one-third of the cases. In comparison of 2008, and 2011 the absolute numbers of LRD as well as LURD have more than doubled from 9 to 20 and 6 to 14 respectively. Based on international ranking data from the global observatory on donation and transplantation Budapest has improved from 1.20 in 2000 to 6.20 LRD per million persons (p.m.p.) in 2010. The increase in LURD has also led to some side effects: an increase in recipient age from 26 years in 2000 to 46 in 2011 and greater HLA mismatches. In 2010, Budapest ranked higher than Croatia or Portugal but still behind Germany (8.13 LRD p.m.p.) and the leading countries: the Netherlands (28.49 LRD p.m.p.) and Norway (16.94 LRD p.m.p.). Because of the tremendous progress in LRD, the gap between today's leading countries and Budapest is closing.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Factors
  • Graft Survival
  • HLA Antigens / immunology
  • Histocompatibility
  • Humans
  • Hungary
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / trends*
  • Living Donors / supply & distribution*
  • Middle Aged
  • Risk Factors
  • Time Factors
  • Tissue and Organ Procurement / trends*
  • Treatment Outcome
  • Young Adult

Substances

  • HLA Antigens